Potential health benefits of sulforaphane: A RE of the experimental, clinical and epidemiological evidences and underlying mechanisms

Journal of Medicinal Plants Research

Volumn 5, Issue 4, 2011, Pages 473-484

  Elbarbry, Fawzy ^a   Elrody, Nehad ^b  

^a PACIFIC UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cancer; CYP enzymes; Herbal remedies; Phase 2 enzymes; Sulforaphane

Indexed keywords

APOPTOSIS INDUCING FACTOR; CURCUMIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOCHROME P450 1A1; CYTOCHROME P450 2B6; CYTOCHROME P450 2C8; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 4A; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHENYL ISOTHIOCYANATE; PLACEBO; PROSTAGLANDIN E2; PROTEIN KINASE C; SULFORAPHANE; THIOREDOXIN; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CELL CYCLE ARREST; CELL PROTECTION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; ENZYME INHIBITION; FOOD INTAKE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FIBROSIS; LUNG CANCER; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROSTATE CANCER; RESPIRATORY TRACT DISEASE; RETINITIS PIGMENTOSA; REVIEW; RISK REDUCTION; SKIN TUMOR; STOMACH DISEASE;

ANIMALIA;

EID: 79953706274     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Ambrosone CB, McCann SE, Freudenheim JL, Marshall JR, Zhang Y, Shields PG (2004). Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J. Nutr., 134: 1134-1138.
2. Angelo LS, Kurzrock R (2007). Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin. Cancer Res., 13: 2825-2830.
3. Angeloni C, Leoncini E, Malaguti M, Angelini S, Hrelia P, Hrelia S (2009). Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential. J. Agric. Food Chem., 57:5615-5622.
4. Baldwin AS (2001). Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest., 107: 241-246.
5. Barcelo S, Gardiner JM, Gescher A, Chipman JK (1996). CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinog., 17: 277-282.
6. Basten GP, Bao Y, Williamson G (2002). Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDPglucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinog., 23: 1399-1404.
7. Beal MF (2009). Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat. Disord. 15 Suppl., 3:S189-S194.
8. Bird AC (1995). Retinal photoreceptor dystrophies LI. Edward Jackson Memorial Lecture. Am. J. Ophthalmol., 119: 543-562.
9. Bogaards JJ, Verhagen H, Willems MI, van PG, van Bladeren PJ (1994). Consumption of Brussels sprouts results in elevated alphaclass glutathione S-transferase levels in human blood plasma. Carcinog., 15: 1073-1075.
10. Boldogh I, Bacsi A, Choudhury BK, Dharajiya N, Alam R, Hazra TK, Mitra S, Goldblum RM, Sur S (2005). ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J. Clin. Invest., 115: 2169-2179.
11. Bowler RP, Crapo JD (2002). Oxidative stress in allergic respiratory diseases. J. Allergy Clin. Immunol., 110: 349-356.
12. Brooks JD, Paton VG, Vidanes G (2001). Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol. Biomarkers Prev., 10: 949-954.
13. Bryant CS, Kumar S, Chamala S, Shah J, Pal J, Haider M, Seward S, Qazi AM, Morris R, Semaan A, Shammas MA, Steffes C, Potti RB, Prasad M, Weaver DW, Batchu RB (2010). Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells. Mol. Cancer. 9: 47.
14. Cheung KL, Khor TO, Kong AN (2009). Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation. Pharm. Res., 26: 224-231.
15. Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC (2002). Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol., 20: 631-636.
16. Clarke JD, Dashwood RH, Ho E (2008). Multi-targeted prevention of cancer by sulforaphane. Cancer Lett., 269: 291-304.
17. Cohen JH, Kristal AR, Stanford JL (2000). Fruit and vegetable intakes and prostate cancer risk. J. Natl. Cancer Inst., 92: 61-68.
18. Conaway CC, Wang CX, Pittman B, Yang YM, Schwartz JE, Tian D, McIntee EJ, Hecht SS, Chung FL (2005). Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res., 65: 8548-8557.
19. Conaway CC, Yang YM, Chung FL (2002). Isothiocyanates as cancer chemopreventive agents: their biological activities and metabolism in rodents and humans. Curr. Drug Metab., 3: 233-255.
20. Danilov CA, Chandrasekaran K, Racz J, Soane L, Zielke C, Fiskum G (2009). Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia., 57: 645-656.
21. Dash PK, Zhao J, Orsi SA, Zhang M, Moore AN (2009). Sulforaphane improves cognitive function administered following traumatic brain injury. Neurosci. Lett., 460: 103-107.
22. Elbarbry FA, McNamara PJ, Alcorn J (2007). Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat. J. Biochem. Mol. Toxicol., 21: 41-50.
23. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, Talalay P, Lozniewski A (2002). Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Nat. l Acad. Sci. U. S. A., 99: 7610-7615.
24. Fahey JW, Zalcmann AT, Talalay P (2001). The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochem., 56: 5-51.
25. Fahey JW, Zhang Y, Talalay P (1997). Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U. S. A., 94: 10367.
26. Galan MV, Kishan AA, Silverman AL (2004). Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report. Dig. Dis. Sci., 49: 1088-1090.
27. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F (2000). Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res., 60:1426-1433.
28. Gao X, nkova-Kostova AT, Talalay P (2001). Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. Proc. Natl. Acad. Sci. U. S. A., 98: 15221-15226.
29. Gao X, Talalay P (2004). Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc. Natl. Acad. Sci. U. S. A., 101: 10446-10451.
30. Gasper AV, Al-Janobi A, Smith JA, Bacon JR, Fortun P, Atherton C, Taylor MA, Hawkey CJ, Barrett DA, Mithen RF (2005). Glutathione Stransferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am. J. Clin. Nutr., 82: 1283-1291.
31. Goosen TC, Mills DE, Hollenberg PF (2001). Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1. J. Pharmacol. Exp. Ther., 296: 198-206.
32. Guerrero-Beltran CE, Calderon-Oliver M, Martinez-Abundis E, Tapia E, Zarco-Marquez G, Zazueta C, Pedraza-Chaverri J (2010). Protective effect of sulforaphane against cisplatin-induced mitochondrial alterations and impairment in the activity of NAD (P)H: Quinone oxidoreductase 1 and gamma glutamyl cysteine ligase: Studies in mitochondria isolated from rat kidney and in LLC-PK1 cells. Toxicol. Lett., 199: 80-92.
33. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C (2001). Nuclear factor kappa B is a molecular target for sulforaphane-mediated antiinflammatory mechanisms. J. Biol. Chem., 276: 32008-32015.
34. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR (1998). Increased skin tumorigenesis in mice lacking pi class glutathione Stransferases. Proc. Natl. Acad. Sci. U. S. A., 95: 5275-5280.
35. Hwang ES, Jeffery EH (2005). Induction of quinone reductase by sulforaphane and sulforaphane N-acetylcysteine conjugate in murine hepatoma cells. J Med Food 8: 198-203.
36. Jiang H, Shang X, Wu H, Huang G, Wang Y, Al-Holou S, Gautam SC, Chopp M (2010). Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochem. Res., 35: 152-161.
37. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, Zhang Y, Marshall JR, Ambrosone CB (2004). Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr. Cancer. 50: 206-213.
38. Juge N, Mithen RF, Traka M (2007). Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol. Life Sci., 64: 1105-1127.
39. Jung Park E, Pezzuto JM (2002). Botanicals in cancer chemoprevention. Cancer Metastasis Rev., 21: 231-255.
40. Keum YS, Yu S, Chang PP, Yuan X, Kim JH, Xu C, Han J, Agarwal A, Kong AN (2006). Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. Cancer Res., 66: 8804-8813.
41. Kong L, Tanito M, Huang Z, Li F, Zhou X, Zaharia A, Yodoi J, McGinnis JF, Cao W (2007). Delay of photoreceptor degeneration in tubby mouse by sulforaphane. J. Neurochem., 101: 1041-1052.
42. Kuroiwa Y, Nishikawa A, Kitamura Y, Kanki K, Ishii Y, Umemura T, Hirose M (2006). Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett., 241: 275-280.
43. Lin H, Hollenberg PF (2001). N-nitrosodimethylamine-mediated formation of oxidized and methylated dna bases in a cytochrome P450 2E1 expressing cell line. Chem. Res. Toxicol., 14: 562-566.
44. Lin HJ, Probst-Hensch NM, Louie AD, Kau IH, Witte JS, Ingles SA, Frankl HD, Lee ER, Haile RW (1998). Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 7: 647-652.
45. Lin W, Wu RT, Wu T, Khor TO, Wang H, Kong AN (2008). Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol., 76: 967-973.
46. Long DJ, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal AK (2002). Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res. 62: 3030-3036.
47. Long DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK (2000). NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res. 60: 5913-5915.
48. Long DJ, Waikel RL, Wang XJ, Roop DR, Jaiswal AK (2001). NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J. Natl. Cancer Inst., 93: 1166-1170.
49. Maheo K, Morel F, Langouet S, Kramer H, Le FE, Ketterer B, Guillouzo A (1997). Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res 57: 3649-3652.
50. Matusheski NV, Jeffery EH (2001). Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J. Agric. Food Chem., 49: 5743-5749.
51. McMorrow T, Gaffney MM, Slattery C, Campbell E, Ryan MP (2005). Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol. Dial. Transplant. 20: 2215-2225.
52. Mi L, Wang X, Govind S, Hood BL, Veenstra TD, Conrads TP, Saha DT, Goldman R, Chung FL (2007). The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res., 67: 6409-6416.
53. Mi L, Xiao Z, Hood BL, Dakshanamurthy S, Wang X, Govind S, Conrads TP, Veenstra TD, Chung FL (2008). Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J. Biol. Chem., 283: 22136-22146.
54. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL (1999). Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J. Natl. Cancer Inst., 91: 605-613.
55. Molavi B, Mehta JL (2004). Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr. Opin. Cardiol., 19: 488-493.
56. Mukherjee PK, Kumar V, Mal M, Houghton PJ (2007). Acetylcholinesterase inhibitors from plants. Phytomed., 14: 289-300.
57. Munday R, Munday CM (2004). Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. J. Agric. Food Chem., 52: 1867-1871.
58. Myzak MC, Dashwood RH (2006). Chemoprotection by sulforaphane: keep one eye beyond Keap1. Cancer Lett., 233: 208-218.
59. Nakajima M, Yoshida R, Shimada N, Yamazaki H, Yokoi T (2001). Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate. Drug Metab. Dispos., 29: 1110-1113.
60. nkova-Kostova AT, Fahey JW, Wade KL, Jenkins SN, Shapiro TA, Fuchs EJ, Kerns ML, Talalay P (2007). Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol. Biomarkers Prev., 16: 847-851.
61. Nkova-Kostova AT, Talalay P (2008). Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol. Nutr. Food Res. 52 Suppl., 1: S128-S138.
62. Nogales E (2000). Structural insights into microtubule function. Annu. Rev. Biochem., 69: 277-302.
63. Noyan-Ashraf MH, Sadeghinejad Z, Juurlink BH (2005). Dietary approach to decrease aging-related CNS inflammation. Nutr. Neurosci., 8: 101-110.
64. Noyan-Ashraf MH, Wu L, Wang R, Juurlink BHJ (2006). Dietary approaches to positively influence fetal determinants of adult health. FASEB J., 20: 1-17.
65. Nyengaard JR, Ido Y, Kilo C, Williamson JR (2004). Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes. 53: 2931-2938.
66. Parker SL, Tong T, Bolden S, Wingo PA (1997). Cancer statistics, 1997. CA Cancer J. Clin., 47: 5-27.
67. Patel R, Garg R, Erande S, Maru B (2007). Chemopreventive herbal anti-oxidants: current status and future perspectives. J. Clin. Biochem. Nutr., 40: 82-91.
68. Payen L, Courtois A, Loewert M, Guillouzo A, Fardel O (2001). Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane. Biochem. Biophys. Res. Commun., 282: 257-263.
69. Ping Z, Liu W, Kang Z, Cai J, Wang Q, Cheng N, Wang S, Wang S, Zhang JH, Sun X (2010). Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Research.
70. Ragheb A, Attia A, Eldin WS, Elbarbry F, Gazarin S, Shoker A (2009). The Protective Effect of Thymoquinone, an Anti-oxidant and Antiinflammatory Agent, against Renal Injury: A Review. Saudi J Kidney Dis. Transpl. 20: 741-752.
71. Riedl MA, Saxon A, az-Sanchez D (2009). Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway. Clin. Immunol., 130: 244-251.
72. Ritz SA, Wan J, az-Sanchez D (2007). Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract. Am. J. Physiol. Lung Cell Mol. Physiol., 292: L33-L39.
73. Rose P, Won YK, Ong CN, Whiteman M (2005). Beta-phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages. Nitric Oxide., 12: 237-243.
74. Seow A, Yuan JM, Sun CL, Van Den BD, Lee HP, Yu MC (2002). Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinog., 23: 2055-2061.
75. Shan Y, Sun C, Zhao X, Wu K, Cassidy A, Bao Y (2006). Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells. Int. J. Oncol., 29: 883-888.
76. Shankar S, Ganapathy S, Srivastava RK (2008). Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin. Cancer Res., 14: 6855-6866.
77. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P (2001). Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer Epidemiol Biomarkers Prev., 10: 501-508.
78. Shen G, Xu C, Chen C, Hebbar V, Kong AN (2006). p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother. Pharmacol., 57: 317-327.
79. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270: 414-423.
80. Shin DH, Park HM, Jung KA, Choi HG, Kim JA, Kim DD, Kim SG, Kang KW, Ku SK, Kensler TW, Kwak MK (2010). The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelialmesenchymal transition and renal fibrosis. Free Radic. Biol. Med., 48: 1051-1063.
81. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV (2004). Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinog., 25: 83-90.
82. Singh SV, Warin R, Xiao D, Powolny AA, Stan SD, Arlotti JA, Zeng Y, Hahm ER, Marynowski SW, Bommareddy A, Desai D, Amin S, Parise RA, Beumer JH, Chambers WH (2009). Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res., 69: 2117-2125.
83. Skupinska K, Misiewicz-Krzeminska I, Lubelska K, Kasprzycka-Guttman T (2009a). The effect of isothiocyanates on CYP1A1 and CYP1A2 activities induced by polycyclic aromatic hydrocarbons in Mcf7 cells. Toxicol. In Vitro. 23: 763-771.
84. Skupinska K, Misiewicz-Krzeminska I, Stypulkowski R, Lubelska K, Kasprzycka-Guttman T (2009b) Sulforaphane and its analogues inhibit CYP1A1 and CYP1A2 activity induced by benzo[a]pyrene. J. Biochem. Mol. Toxicol. 23: 18-28.
85. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, So HS, Park R, Kwon KB, Park BH (2009). Sulforaphane protects against cytokine-and streptozotocin-induced beta-cell damage by suppressing the NFkappaB pathway. Toxicol. Appl. Pharmacol., 235: 57-67.
86. Spitz MR, Duphorne CM, Detry MA, Pillow PC, Amos CI, Lei L, de AM, Gu X, Hong WK, Wu X (2000). Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev., 9: 1017-1020.
87. Steck SE, Gammon MD, Hebert JR, Wall DE, Zeisel SH (2007). GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary isothiocyanate metabolites following broccoli consumption in humans. J. Nutr., 137: 904-909.
88. Talalay P (2000). Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors. 12: 5-11.
89. Telang U, Brazeau DA, Morris ME (2009). Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells. Exp. Biol. Med. (Maywood). 234: 287-295.
90. Trinh K, Moore K, Wes PD, Muchowski PJ, Dey J, Andrews L, Pallanck LJ (2008). Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease. J. Neurosci., 28: 465-472.
91. Vermeulen M, Klopping-Ketelaars IW, Van den BR, Vaes WH (2008). Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J. Agric. Food Chem. 56: 10505-10509.
92. Wattanapitayakul SK, Bauer JA (2001). Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol. Ther., 89: 187-206.
93. Woo KJ, Kwon TK (2007). Sulforaphane suppresses lipopolysaccharide-induced cyclooxygenase-2 (COX-2) expression through the modulation of multiple targets in COX-2 gene promoter. Int Immunopharmacol 7: 1776-1783.
94. Woolf TF, Thomas F (1999). Handbbok of Drug Metab., pp. 596-630.
95. Woolf TF, Jordan RA (1987). Basic concepts in drug metabolism: Part Int. J. Clin. Pharmacol., 27: 15-17.
96. Wu L, Ashraf M, Facci M, Wang R, Paterson PG, Ferrie A, Juurlink BHJ (2004). Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system. Proc. Natl. Acad. Sci. U.S.A., 101: 7094.
97. Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, Conney AH, Kong AN (2006). Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res., 66: 8293-8296.
98. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, Thornalley PJ (2008). Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes. 57: 2809-2817.
99. Yamada K, Yamamiya I, Utsumi H (2006). In vivo detection of free radicals induced by diethylnitrosamine in rat liver tissue. Free Radic. Biol. Med., 40: 2040-2046.
100. Yanaka A, Fahey JW, Fukumoto A, Nakayama M, Inoue S, Zhang S, Tauchi M, Suzuki H, Hyodo I, Yamamoto M (2009). Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev. Res. (Phila Pa). 2: 353-360.
101. Yoon HY, Kang NI, Lee HK, Jang KY, Park JW, Park BH (2008). Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem. Pharmacol., 75: 2214-2223.
102. Yoxall V, Kentish P, Coldham N, Kuhnert N, Sauer MJ, Ioannides C (2005). Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: Implications for its chemopreventive activity. Int. J. Cancer. 117: 356-362.
103. Yu R, Lei W, Mandlekar S, Weber MJ, Der CJ, Wu J, Kong AN (1999). Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem., 274: 27545-27552.
104. Zakkar M, Van der HK, Luong lA, Chaudhury H, Cuhlmann S, Hamdulay SS, Krams R, Edirisinghe I, Rahman I, Carlsen H, Haskard DO, Mason JC, Evans PC (2009). Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler. Thromb. Vasc. Biol., 29: 1851-1857.
105. Zhang SM, Hunter DJ, Rosner BA, Giovannucci EL, Colditz GA, Speizer FE, Willett WC (2000). Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol. Biomarkers Prev., 9: 477-485.
106. Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. U. S. A., 91: 3147-3150.
107. Zhang Y, Munday R, Jobson HE, Munday CM, Lister C, Wilson P, Fahey JW, Mhawech-Fauceglia P (2006). Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli (Brassica oleracea italica) sprouts. J. Agric. Food Chem., 54: 9370-9376.
108. Zhang Y, Talalay P, Cho CG, Posner GH (1992). A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U. S. A., 89: 2399-2403.
109. Zhao H, Lin J, Grossman HB, Hernandez LM, Dinney CP, Wu X (2007). Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int. J. Cancer, 120: 2208-2213.
110. Zhao J, Kobori N, Aronowski J, Dash PK (2006). Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci. Lett., 393: 108-112.